Related Experiment Video
Updated: Oct 30, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
Christophe Delehedde1,2, Luc Even2, Patrick Midoux1
1Innovative Therapies & Nanomedicine, Centre de Biophysique Moléculaire CNRS UPR4301, Rue Charles Sadron, 45071 Orléans, France.
Abstract:
Messenger RNA (mRNA) is being extensively used in gene therapy and vaccination due to its safety over DNA, in the following ways: its lack of integration risk, cytoplasmic expression, and transient expression compatible with fine regulations. However, clinical applications of mRNA are limited by its fast degradation by nucleases, and the activation of detrimental immune responses. Advances in mRNA applications, with the recent approval of COVID-19 vaccines, were fueled by optimization of the mRNA sequence and the development of mRNA delivery systems. Although delivery systems and mRNA sequence optimization have been abundantly reviewed, understanding of the intracellular processing of mRNA is mandatory to improve its applications. We will focus on lipid nanoparticles (LNPs) as they are the most advanced nanocarriers for the delivery of mRNA. Here, we will review how mRNA therapeutic potency can be affected by its interactions with cellular proteins and intracellular distribution.
Insights
Messenger RNA (mRNA) therapies are promising but face challenges. Optimizing mRNA delivery and understanding its intracellular journey are key to improving therapeutic effectiveness and safety for vaccines and gene therapy.
Area of Science:
- Biotechnology and Molecular Medicine
- Nanomedicine and Drug Delivery
Background:
- Messenger RNA (mRNA) offers safety advantages over DNA for gene therapy and vaccines, including no integration risk and transient expression.
- Clinical mRNA applications are hindered by rapid degradation and immunogenicity, necessitating advancements in sequence optimization and delivery systems.
- Recent successes, like COVID-19 vaccines, highlight the impact of improved mRNA technology.
Purpose of the Study:
- To review the intracellular processing of mRNA, focusing on its interactions with cellular proteins and distribution.
- To understand how these intracellular events impact mRNA therapeutic potency.
- To highlight the importance of intracellular processing for advancing mRNA applications beyond current delivery and sequence optimization strategies.
Main Methods:
- Review of existing literature on mRNA intracellular processing.
- Focus on lipid nanoparticles (LNPs) as the primary delivery vehicle for mRNA.
- Analysis of how cellular protein interactions and intracellular distribution affect mRNA function.
Main Results:
- mRNA therapeutic potency is significantly influenced by its interactions with cellular proteins.
- Intracellular distribution patterns of mRNA affect its translation efficiency and therapeutic outcome.
- Lipid nanoparticles (LNPs) are the most advanced nanocarriers, but their efficacy depends on intracellular dynamics.
Conclusions:
- Understanding mRNA's intracellular journey is crucial for enhancing its therapeutic applications.
- Further research into cellular interactions and distribution is mandatory for optimizing mRNA-based therapies and vaccines.
- Targeting intracellular processing mechanisms can unlock the full potential of mRNA technology.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Regulated mRNA Transport
Introduction to Membrane Traffic
The transport of soluble and membrane proteins is mediated by transport vesicles that collect cargo from one cellular compartment and deliver it to another by fusing with the target organelle membrane. The Rab...
Nuclear Export of mRNA
Regulation of Nuclear Protein Sorting

